Booth Robert F. has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 7180 shares of Summit Therapeutics Inc. ($SMMT) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 7180 | $8.76 | 7,180.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 6855 | $9.18 | 6,855.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 47651 | $1.32 | 82,651.0000 | 0 | 136.15% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Booth Robert F. | Director | A | Stock Option (right to buy) | 32700 | $1.67 | 67,700.0000 | 0 | 93.43% | 0.00% |